Crewe Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

Crewe Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-269	Closed	-$7.25K	–	1066
2022 Q4	$7.25K	Hold	269	–	–	﹤0.01%	608
2022 Q3	$5K	Hold	269	–	–	﹤0.01%	868
2022 Q2	$3K	Buy	+269	New	+$2.97K	﹤0.01%	945

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crewe Advisors's MYOV Position: Q1 2023 in Review

Crewe Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 269 shares — an estimated $7.25K sold.

Crewe Advisors first reported a position in MYOV in Q2 2022 and held it in 3 quarters. The position peaked at $7.25K in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Crewe Advisors reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Crewe Advisors sold 269 Myovant Sciences Ltd. shares in Q1 2023, an estimated $7.25K.
Crewe Advisors first reported a position in Myovant Sciences Ltd. in Q2 2022 and held it in 3 quarters.
Crewe Advisors's Myovant Sciences Ltd. position peaked at $7.25K in Q4 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Crewe Advisors's 13F filing for Q1 2023, filed 12 May 2023.